Type I Diabetes Mellitus Pathway

Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma). (NCI Thesaurus/KEGG)

YOU MAY ALSO LIKE

Type I Collagen N-Telopeptide Measurement

The determination of the amount of the type I collagen N-telopeptide present in a sample.

Type I Collagen C-Telopeptide Measurement

The determination of the amount of the type I collagen C-telopeptide present in a sample.

Type I Acrocephalosyndactyly

An autosomal dominant inherited type of acrocephalosyndactyly caused by mutations in the FGFR2 gene. It is characterized by early closure of the…

Type D Retrovirus

A genus of the family RETROVIRIDAE consisting of oncogenic exogenous retroviruses that contain type D particles. They include the type species, MASON-PFIZER…

Type Code

A coded value specifying an identifiable class of an entity or activity based on common qualities.

type C thymoma

A rare type of thymus gland cancer. It usually spreads, has a high risk of recurrence, and has a poor survival…